Pleiotropic effects of niacin: Current possibilities for its clinical use
Niacin was the first hypolipidemic drug to significantly reduce both major cardiovascular events and mortality in patients with cardiovascular disease. Niacin favorably influences all lipoprotein classes, including lipoprotein[a],and belongs to the most potent hypolipidemic drugs for increasing HDL-...
Main Authors: | Zeman Miroslav, Vecka Marek, Perlík František, Staňková Barbora, Hromádka Robert, Tvrzická Eva, Širc Jakub, Hrib Jakub, Žák Aleš |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.1515/acph-2016-0043 |
Similar Items
-
A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01) -
A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Salim Ahmed, et al.
Published: (2008-06-01) -
Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin
by: Anbu Pandian, et al.
Published: (2008-10-01) -
Randomized Comparative Study of the Effects of Treatment with Once-Daily, Niacin Extended-Release/Lovastatin and with Simvastatin on Lipid Profile and Fibrinolytic Parameters in Taiwan
by: Tsung-Hsien Lin, et al.
Published: (2006-06-01) -
Combinação de fármacos na abordagem das dislipidemias: associação entre estatinas e niacina Combination of drugs: statins and niacin
by: Jairo Lins Borges
Published: (2005-10-01)